u/PeepoIsLife

Hey all,

I don't have a lot of knowledge about Biopharma.

If it for any reason fails and there is no buyout, then the stock will fall. So far so good.

But that doesn't mean that's it or? They obviously made huge progress due to patients living far longer than expected. So whatever they have right now is promising... when the results come in, can't their build upon that knowledge, tweak things and have another Trial with an improved product?

Is there a realistic scenario where there is no buyout but still retail? What would that mean for investors?

Or is it literally lights out, everyone goes home. I somehow can't imagine that as there should be ambition to keep digging.

Thanks

Hey all,

I don't have a lot of knowledge about Biopharma.

If it for any reason fails and there is no buyout, then the stock will fall. So far so good.

But that doesn't mean that's it or? They obviously made huge progress due to patients living far longer than expected. So whatever they have right now is promising... when the results come in, can't their build upon that knowledge, tweak things and have another Trial with an improved product?

Is there a realistic scenario where there is no buyout but still retail? What would that mean for investors?

Or is it literally lights out, everyone goes home. I somehow can't imagine that as there should be ambition to keep digging.

Thanks

I'm fairly new to investing, do a lot of reading here on reddit but want to make sure I don't do a massive mistake. I obviously don't know much yet but working on it.

I live in Germany and can (did) buy Sk hynix stock. I'm using Scalable Capital App.

To my understanding US has to buy the Korean version currently with a foreign app or whatever to invest into Sk Hynix.

Sk is now coming to the US Market which enables institutes and ETF's to also buy Sk as they are otherwise not allowed to dip into foreign markets.

My big question: My European one is linked to the Korean one.. so if the Korean versions moves, so does my Europe one and vice versa? Currently it's like 1550€.

Does this mean when the US gets its listing.. it will be about 1700$? Are we all tied together? So when Americans and institutions and American ETF's can purchase the US stock, my European one should rise or fall aswell?

And if that what I wrote is correct, then it should be a no brainer for me to stock up on SK as I have access to it now already.

Not looking for financial advise to buy or not to buy! Just trying to understand how this works. I don't want to lose money because I didnt understand how it works and the US version ends up being it's own Stock for example.

Thanks to anyone who takes their time for this, I appreciate it.

Ich habe eine Direktversicherung bei der Canadalife.

Arbeitgeberanteil 33% mein Anteil 67%

Beitrag 305 Euro... also ungefähr 100 Euro Arbeitgeber und 205 Euro ich. Laufzeit 35 Jahre also bis 67. 2% Dynamik

Es ist zu meinem Verständnis, dass meine 205 Euro Brutto sind, also echter Nettoverlust vom Gehalt sind 100 Euro.

Auf plump gesagt, ich verliere 100 Euro monatlich. Mindestauszahlung bei ablauf ist 230k angegeben... bis dahin wären 122k von "uns" eingezahlt.

Ist das überhaupt Sinnvoll? Momentan nach fast 5 Jahren sind von 16k Einzahlung nur 8k übrig, rest wurde von Kosten gefressen... die sich laut Canadalife nach 5 Jahren drastisch mindern.

Wenn ich diese Direktversicherung kündige.. hätte ich ja effektiv nur 100 Euro netto mehr... ich denke nicht dass eine 100 Euro ETF diese Direktversicherung schlagen kann?

Hinzu kommt was sehr wichtig ist: Ich werde Zeitnah der Geschäftsführer werden.

Wäre echt um jeden Rat dankbar, da ich überlege in den sauren Apfel zu beißen und lieber jetzt kündigen als später in 10 Jahren falls das doch mist ist.

Vielen Dank